The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2022 | Key takeaways in leukemia at ASCO 2022
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, provides an overview of key updates in leukemia presented at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, including novel approaches using bispecific antibodies, as well as targeted approaches in acute myeloid leukemia (AML). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.
